| Symbol |
Name |
|
ADCY1
|
adenylate cyclase 1 (brain)
|
|
ADCY10
|
adenylate cyclase 10 (soluble)
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADCY3
|
adenylate cyclase 3
|
|
ADCY4
|
adenylate cyclase 4
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADCY6
|
adenylate cyclase 6
|
|
ADCY7
|
adenylate cyclase 7
|
|
ADCY8
|
adenylate cyclase 8 (brain)
|
|
ADCY9
|
adenylate cyclase 9
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGAP1
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
|
|
AKAP5
|
A kinase (PRKA) anchor protein 5
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCT7
|
chaperonin containing TCP1, subunit 7 (eta)
|
|
CD38
|
CD38 molecule
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTGF
|
connective tissue growth factor
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CYGB
|
cytoglobin
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DRD2
|
dopamine receptor D2
|
|
FPR2
|
formyl peptide receptor 2
|
|
GCG
|
glucagon
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAS
|
GNAS complex locus
|
|
GPR65
|
G protein-coupled receptor 65
|
|
GUCA1A
|
guanylate cyclase activator 1A (retina)
|
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2
|
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3
|
|
GUCY1B2
|
guanylate cyclase 1, soluble, beta 2 (pseudogene)
|
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
|
IFNG
|
interferon, gamma
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
KRT20
|
keratin 20, type I
|
|
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
|
|
MAPT
|
microtubule-associated protein tau
|
|
MIR142
|
microRNA 142
|
|
MIR181B1
|
microRNA 181b-1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MYCBP2
|
MYC binding protein 2, E3 ubiquitin protein ligase
|
|
NOP16
|
NOP16 nucleolar protein
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH3
|
notch 3
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPPC
|
natriuretic peptide C
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NTN1
|
netrin 1
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P2RY13
|
purinergic receptor P2Y, G-protein coupled, 13
|
|
PDZD3
|
PDZ domain containing 3
|
|
PNPLA6
|
patatin-like phospholipase domain containing 6
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
QPCT
|
glutaminyl-peptide cyclotransferase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RD3
|
retinal degeneration 3
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHOA
|
ras homolog family member A
|
|
RLN2
|
relaxin 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSTR4
|
somatostatin receptor 4
|
|
STIM1
|
stromal interaction molecule 1
|
|
TGM2
|
transglutaminase 2
|
|
TKFC
|
triokinase/FMN cyclase
|
|
TNF
|
tumor necrosis factor
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
UTS2R
|
urotensin 2 receptor
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
